HEADER OXIDOREDUCTASE 20-SEP-05 2B3D TITLE CRYSTAL STRUCTURE OF MODULATOR OF DRUG ACTIVITY B IN COMPLEX WITH TITLE 2 FLAVIN ADENINE DINUCLEOTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: MODULATOR OF DRUG ACTIVITY B; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS MODULATOR OF DRUG ACTIVITY B, NAD(P)H:OXIDOREDUCTASE; DT-DIAPHORASE; KEYWDS 2 MENADIONE REDUCTASE; QUINONE, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR M.A.ADAMS,Z.JIA REVDAT 5 20-SEP-23 2B3D 1 REMARK REVDAT 4 31-MAY-23 2B3D 1 REMARK SEQADV REVDAT 3 11-OCT-17 2B3D 1 REMARK REVDAT 2 24-FEB-09 2B3D 1 VERSN REVDAT 1 29-AUG-06 2B3D 0 JRNL AUTH M.A.ADAMS,Z.JIA JRNL TITL MODULATOR OF DRUG ACTIVITY B FROM ESCHERICHIA COLI: CRYSTAL JRNL TITL 2 STRUCTURE OF A PROKARYOTIC HOMOLOGUE OF DT-DIAPHORASE. JRNL REF J.MOL.BIOL. V. 359 455 2006 JRNL REFN ISSN 0022-2836 JRNL PMID 16630630 JRNL DOI 10.1016/J.JMB.2006.03.053 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 20168 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 984 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3069 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 106 REMARK 3 SOLVENT ATOMS : 413 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.350 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.96 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.825 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2B3D COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-OCT-05. REMARK 100 THE DEPOSITION ID IS D_1000034624. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-AUG-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23420 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.95000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.29100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2AMJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG3350, CALCIUM CHLORIDE, PH 8, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 42.05250 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6670 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15430 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -41.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 465 SER A 3 REMARK 465 SER A 4 REMARK 465 HIS A 5 REMARK 465 HIS A 6 REMARK 465 HIS A 7 REMARK 465 HIS A 8 REMARK 465 HIS A 9 REMARK 465 HIS A 10 REMARK 465 GLY A 11 REMARK 465 MET B 1 REMARK 465 GLY B 2 REMARK 465 SER B 3 REMARK 465 SER B 4 REMARK 465 HIS B 5 REMARK 465 HIS B 6 REMARK 465 HIS B 7 REMARK 465 HIS B 8 REMARK 465 HIS B 9 REMARK 465 HIS B 10 REMARK 465 GLY B 11 REMARK 465 ARG B 112 REMARK 465 LYS B 113 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 24 132.84 179.81 REMARK 500 ALA A 25 87.36 25.37 REMARK 500 HIS A 26 -32.13 83.08 REMARK 500 SER A 107 -160.74 -176.13 REMARK 500 PHE A 149 -51.03 -29.89 REMARK 500 HIS A 151 15.31 56.46 REMARK 500 MET A 185 58.18 -114.27 REMARK 500 PRO A 189 -179.58 -57.54 REMARK 500 ARG A 190 -63.01 104.69 REMARK 500 LYS B 23 -106.04 -52.10 REMARK 500 PHE B 24 118.95 52.77 REMARK 500 ALA B 25 -134.49 51.93 REMARK 500 THR B 103 -45.54 -133.81 REMARK 500 SER B 107 -163.89 -169.23 REMARK 500 PRO B 115 90.33 -4.42 REMARK 500 SER B 116 -48.93 168.49 REMARK 500 HIS B 151 42.25 -50.40 REMARK 500 PRO B 189 -178.36 -67.73 REMARK 500 ARG B 190 -55.05 114.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD A 1205 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD B 1206 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2AMJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MODULATOR OF DRUG ACTIVITY B DBREF 2B3D A 13 204 UNP P0AEY5 MDAB_ECOLI 2 193 DBREF 2B3D B 13 204 UNP P0AEY5 MDAB_ECOLI 2 193 SEQADV 2B3D MET A 1 UNP P0AEY5 CLONING ARTIFACT SEQADV 2B3D GLY A 2 UNP P0AEY5 CLONING ARTIFACT SEQADV 2B3D SER A 3 UNP P0AEY5 CLONING ARTIFACT SEQADV 2B3D SER A 4 UNP P0AEY5 CLONING ARTIFACT SEQADV 2B3D HIS A 5 UNP P0AEY5 EXPRESSION TAG SEQADV 2B3D HIS A 6 UNP P0AEY5 EXPRESSION TAG SEQADV 2B3D HIS A 7 UNP P0AEY5 EXPRESSION TAG SEQADV 2B3D HIS A 8 UNP P0AEY5 EXPRESSION TAG SEQADV 2B3D HIS A 9 UNP P0AEY5 EXPRESSION TAG SEQADV 2B3D HIS A 10 UNP P0AEY5 EXPRESSION TAG SEQADV 2B3D GLY A 11 UNP P0AEY5 CLONING ARTIFACT SEQADV 2B3D SER A 12 UNP P0AEY5 CLONING ARTIFACT SEQADV 2B3D MET B 1 UNP P0AEY5 CLONING ARTIFACT SEQADV 2B3D GLY B 2 UNP P0AEY5 CLONING ARTIFACT SEQADV 2B3D SER B 3 UNP P0AEY5 CLONING ARTIFACT SEQADV 2B3D SER B 4 UNP P0AEY5 CLONING ARTIFACT SEQADV 2B3D HIS B 5 UNP P0AEY5 EXPRESSION TAG SEQADV 2B3D HIS B 6 UNP P0AEY5 EXPRESSION TAG SEQADV 2B3D HIS B 7 UNP P0AEY5 EXPRESSION TAG SEQADV 2B3D HIS B 8 UNP P0AEY5 EXPRESSION TAG SEQADV 2B3D HIS B 9 UNP P0AEY5 EXPRESSION TAG SEQADV 2B3D HIS B 10 UNP P0AEY5 EXPRESSION TAG SEQADV 2B3D GLY B 11 UNP P0AEY5 CLONING ARTIFACT SEQADV 2B3D SER B 12 UNP P0AEY5 CLONING ARTIFACT SEQRES 1 A 204 MET GLY SER SER HIS HIS HIS HIS HIS HIS GLY SER SER SEQRES 2 A 204 ASN ILE LEU ILE ILE ASN GLY ALA LYS LYS PHE ALA HIS SEQRES 3 A 204 SER ASN GLY GLN LEU ASN ASP THR LEU THR GLU VAL ALA SEQRES 4 A 204 ASP GLY THR LEU ARG ASP LEU GLY HIS ASP VAL ARG ILE SEQRES 5 A 204 VAL ARG ALA ASP SER ASP TYR ASP VAL LYS ALA GLU VAL SEQRES 6 A 204 GLN ASN PHE LEU TRP ALA ASP VAL VAL ILE TRP GLN MET SEQRES 7 A 204 PRO GLY TRP TRP MET GLY ALA PRO TRP THR VAL LYS LYS SEQRES 8 A 204 TYR ILE ASP ASP VAL PHE THR GLU GLY HIS GLY THR LEU SEQRES 9 A 204 TYR ALA SER ASP GLY ARG THR ARG LYS ASP PRO SER LYS SEQRES 10 A 204 LYS TYR GLY SER GLY GLY LEU VAL GLN GLY LYS LYS TYR SEQRES 11 A 204 MET LEU SER LEU THR TRP ASN ALA PRO MET GLU ALA PHE SEQRES 12 A 204 THR GLU LYS ASP GLN PHE PHE HIS GLY VAL GLY VAL ASP SEQRES 13 A 204 GLY VAL TYR LEU PRO PHE HIS LYS ALA ASN GLN PHE LEU SEQRES 14 A 204 GLY MET GLU PRO LEU PRO THR PHE ILE ALA ASN ASP VAL SEQRES 15 A 204 ILE LYS MET PRO ASP VAL PRO ARG TYR THR GLU GLU TYR SEQRES 16 A 204 ARG LYS HIS LEU VAL GLU ILE PHE GLY SEQRES 1 B 204 MET GLY SER SER HIS HIS HIS HIS HIS HIS GLY SER SER SEQRES 2 B 204 ASN ILE LEU ILE ILE ASN GLY ALA LYS LYS PHE ALA HIS SEQRES 3 B 204 SER ASN GLY GLN LEU ASN ASP THR LEU THR GLU VAL ALA SEQRES 4 B 204 ASP GLY THR LEU ARG ASP LEU GLY HIS ASP VAL ARG ILE SEQRES 5 B 204 VAL ARG ALA ASP SER ASP TYR ASP VAL LYS ALA GLU VAL SEQRES 6 B 204 GLN ASN PHE LEU TRP ALA ASP VAL VAL ILE TRP GLN MET SEQRES 7 B 204 PRO GLY TRP TRP MET GLY ALA PRO TRP THR VAL LYS LYS SEQRES 8 B 204 TYR ILE ASP ASP VAL PHE THR GLU GLY HIS GLY THR LEU SEQRES 9 B 204 TYR ALA SER ASP GLY ARG THR ARG LYS ASP PRO SER LYS SEQRES 10 B 204 LYS TYR GLY SER GLY GLY LEU VAL GLN GLY LYS LYS TYR SEQRES 11 B 204 MET LEU SER LEU THR TRP ASN ALA PRO MET GLU ALA PHE SEQRES 12 B 204 THR GLU LYS ASP GLN PHE PHE HIS GLY VAL GLY VAL ASP SEQRES 13 B 204 GLY VAL TYR LEU PRO PHE HIS LYS ALA ASN GLN PHE LEU SEQRES 14 B 204 GLY MET GLU PRO LEU PRO THR PHE ILE ALA ASN ASP VAL SEQRES 15 B 204 ILE LYS MET PRO ASP VAL PRO ARG TYR THR GLU GLU TYR SEQRES 16 B 204 ARG LYS HIS LEU VAL GLU ILE PHE GLY HET FAD A1205 53 HET FAD B1206 53 HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE FORMUL 3 FAD 2(C27 H33 N9 O15 P2) FORMUL 5 HOH *413(H2 O) HELIX 1 1 GLY A 29 LEU A 46 1 18 HELIX 2 2 ASP A 60 ALA A 71 1 12 HELIX 3 3 PRO A 86 GLY A 100 1 15 HELIX 4 4 MET A 140 GLU A 145 1 6 HELIX 5 5 GLY A 154 TYR A 159 1 6 HELIX 6 6 TYR A 159 LEU A 169 1 11 HELIX 7 7 ARG A 190 GLY A 204 1 15 HELIX 8 8 GLY B 29 LEU B 46 1 18 HELIX 9 9 ASP B 60 ALA B 71 1 12 HELIX 10 10 PRO B 86 GLY B 100 1 15 HELIX 11 11 MET B 140 GLU B 145 1 6 HELIX 12 12 GLY B 154 TYR B 159 1 6 HELIX 13 13 TYR B 159 PHE B 168 1 10 HELIX 14 14 ARG B 190 GLY B 204 1 15 SHEET 1 A 5 ASP A 49 ARG A 54 0 SHEET 2 A 5 ASN A 14 ASN A 19 1 N ILE A 17 O ARG A 51 SHEET 3 A 5 VAL A 73 PRO A 79 1 O ILE A 75 N ILE A 18 SHEET 4 A 5 LYS A 129 THR A 135 1 O MET A 131 N TRP A 76 SHEET 5 A 5 GLU A 172 PRO A 173 1 O GLU A 172 N TYR A 130 SHEET 1 B 5 ASP A 49 ARG A 54 0 SHEET 2 B 5 ASN A 14 ASN A 19 1 N ILE A 17 O ARG A 51 SHEET 3 B 5 VAL A 73 PRO A 79 1 O ILE A 75 N ILE A 18 SHEET 4 B 5 LYS A 129 THR A 135 1 O MET A 131 N TRP A 76 SHEET 5 B 5 PHE A 177 ALA A 179 1 O PHE A 177 N LEU A 134 SHEET 1 C 5 ASP B 49 ARG B 54 0 SHEET 2 C 5 ASN B 14 ASN B 19 1 N ILE B 15 O ASP B 49 SHEET 3 C 5 VAL B 73 PRO B 79 1 O ILE B 75 N ILE B 18 SHEET 4 C 5 LYS B 129 THR B 135 1 O MET B 131 N TRP B 76 SHEET 5 C 5 GLU B 172 PRO B 173 1 O GLU B 172 N TYR B 130 SHEET 1 D 5 ASP B 49 ARG B 54 0 SHEET 2 D 5 ASN B 14 ASN B 19 1 N ILE B 15 O ASP B 49 SHEET 3 D 5 VAL B 73 PRO B 79 1 O ILE B 75 N ILE B 18 SHEET 4 D 5 LYS B 129 THR B 135 1 O MET B 131 N TRP B 76 SHEET 5 D 5 PHE B 177 ALA B 179 1 O PHE B 177 N LEU B 134 CISPEP 1 VAL A 188 PRO A 189 0 0.49 CISPEP 2 VAL B 188 PRO B 189 0 0.21 SITE 1 AC1 27 PHE A 24 ALA A 25 HIS A 26 SER A 27 SITE 2 AC1 27 ASN A 28 GLY A 29 GLN A 30 LEU A 31 SITE 3 AC1 27 ASN A 32 THR A 34 PRO A 79 GLY A 80 SITE 4 AC1 27 TRP A 81 TRP A 82 MET A 83 THR A 135 SITE 5 AC1 27 TRP A 136 ASN A 137 ALA A 138 VAL A 182 SITE 6 AC1 27 HOH A1215 HOH A1250 HOH A1263 HOH A1334 SITE 7 AC1 27 HOH A1398 THR B 98 TYR B 119 SITE 1 AC2 29 THR A 98 TYR A 119 ARG A 190 PHE B 24 SITE 2 AC2 29 HIS B 26 SER B 27 ASN B 28 GLY B 29 SITE 3 AC2 29 GLN B 30 LEU B 31 ASN B 32 THR B 34 SITE 4 AC2 29 PRO B 79 GLY B 80 TRP B 81 TRP B 82 SITE 5 AC2 29 MET B 83 THR B 135 TRP B 136 ASN B 137 SITE 6 AC2 29 ALA B 138 VAL B 182 HOH B1220 HOH B1224 SITE 7 AC2 29 HOH B1245 HOH B1260 HOH B1315 HOH B1347 SITE 8 AC2 29 HOH B1393 CRYST1 48.626 84.105 55.490 90.00 110.95 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020565 0.000000 0.007874 0.00000 SCALE2 0.000000 0.011890 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019297 0.00000